Skip to content

A Cohort Study on High-Risk Thyroid Genes, Lymph Node Metastasis, and Prognosis

A Cohort Study on High-Risk Thyroid Genes, Lymph Node Metastasis, and Prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115739
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tthyroid cancer

Interventions

Observation group:N/A

Sponsors

Liuzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Thyroid cancer patients who voluntarily participate in the study and sign an informed consent form; 2.Aged between 14 and 70 years. 3.Patients diagnosed with thyroid cancer and receiving treatment.

Exclusion criteria

Exclusion criteria: 1.Patients with other serious illnesses (such as end-stage renal disease, severe liver disease, etc.); 2.Patients who have participated in other clinical trials within the six months prior to the study.

Design outcomes

Primary

MeasureTime frame
RET Gene;RAS Gene;BRAF Gene;Thyroid-Stimulating Hormone;

Countries

China

Contacts

Public ContactQin Shuting

Liuzhou People's Hospital

24661789@qq.com+86 772 266 2912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026